Bio-Rad (BIO)
$342.4 0.6%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bio-Rad, AI stock picks, stock alerts and much more.
BIO AI Stock Analysis
AI stock analysis for BIO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bio-Rad (BIO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BIO Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bio-Rad (BIO), currently trading at $342.4, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BIO
-
Bio-Rad Laboratories, Inc.
-
Symbol
BIO
-
Market
NYSE
-
Industry
Medical - Devices
-
Market Cap
9.6B
Similar Stocks
 |
Abbott Laboratories ABT |
$113.5 0.4% |
5 |
 |
Boston Scientific BSX |
$98.66 0.5% |
6 |
 |
Edwards Lifesciences EW |
$69.78 0.1% |
4 |
 |
Medtronic MDT |
$88.08 1.1% |
5 |
 |
Stryker SYK |
$383.4 0.4% |
5 |
News
BIO Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Instagram Followers
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
BIO Financials
BIO Key Metrics
-
Total Revenue
$649.7M
-
Net Income
$653.2M
-
Earnings per Share
$23.09
-
Free cash flow
$246.7M
-
EBITDA
$1.4B
-
EBITDA Ratio
2.13899
-
Total Assets
$10.6B
BIO 2-year Revenue & Income
BIO 2-year Free Cash Flow
BIO Technicals
BIO SMA
BIO RSI
FAQ
What's the current price of Bio-Rad (BIO) Stock?
The price of an Bio-Rad (BIO) share is $342.4.
What's the market cap of Bio-Rad?
The current market cap of Bio-Rad is 9.6B.
Should I buy or sell BIO?
Bio-Rad shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Bio-Rad is better viewed as a hold or accumulate position while waiting for further developments.
Is Bio-Rad a good investment?
The current analysis of Bio-Rad's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Bio-Rad's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Bio-Rad (BIO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Bio-Rad stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Bio-Rad (BIO) that investors often compare it to?
Bio-Rad (BIO) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.
What is the forecast for Bio-Rad's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bio-Rad's stock price to be around $339.7 in 2026. Starting from the current price of $342.4, this represents a 0.8% change in price, indicating a neutral outlook for the stock.
How to buy Bio-Rad (BIO) Stock?
Bio-Rad stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bio-Rad shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.